Why Is Tranxene So Hard to Find? [Explained for 2026]

You handed over your prescription for Tranxene and the pharmacist shook their head — out of stock, or maybe they said they don't carry it anymore. If this sounds familiar, you're not imagining things. Tranxene (clorazepate dipotassium) has become increasingly difficult to find at many pharmacies across the United States in 2026. Let's break down exactly why this happens and, more importantly, what you can do right now to get your medication.

What Is Tranxene and Who Takes It?

Tranxene is the brand name for clorazepate dipotassium, a long-acting benzodiazepine FDA-approved for three conditions: anxiety disorders, adjunctive treatment of partial seizures, and acute alcohol withdrawal. It works as a prodrug — after you swallow it, your stomach rapidly converts it to its active form, nordiazepam, which has a half-life of roughly 40 to 50 hours. That long duration is one of Tranxene's key advantages: it delivers steady symptom control throughout the day without the peaks and valleys of shorter-acting benzodiazepines.

Tranxene comes in 3.75 mg, 7.5 mg, and 15 mg tablets and is typically prescribed at doses of 15 to 60 mg per day. Despite being a well-established medication that has been on the market since 1967, filling a Tranxene prescription in 2026 can feel like a scavenger hunt at many pharmacies.

Is Tranxene in an Official FDA Shortage?

As of early 2026, Tranxene (clorazepate) is not formally listed on the FDA Drug Shortage Database. That might sound reassuring — but it doesn't tell the whole story. Many patients are experiencing what's sometimes called a "soft shortage": the drug exists, it's manufactured, and it's not discontinued — but large portions of the supply chain aren't carrying it, making it genuinely difficult to fill your prescription at a standard pharmacy.

Reason 1: Very Few Manufacturers Make Clorazepate

One of the biggest drivers of Tranxene's availability problems is the extremely small number of companies that manufacture it. The brand-name version, Tranxene, is produced by Recordati Rare Diseases Inc. Generic clorazepate has historically come from only a handful of manufacturers. When you have such a limited supplier base, any disruption — a raw material delay, a manufacturing line issue, or a regulatory hold — can ripple across the entire supply chain.

There is some good news: in early 2026, ANI Pharmaceuticals received FDA approval for a new generic clorazepate dipotassium tablet. Adding another manufacturer to the market should help increase overall supply over time and may drive prices down.

Reason 2: Low Demand Means Pharmacies Don't Stock It

Tranxene isn't prescribed nearly as often as other benzodiazepines like alprazolam (Xanax), lorazepam (Ativan), or clonazepam (Klonopin). Because demand is lower, many large chain pharmacies simply don't keep it as a regular inventory item. They prioritize shelf space for high-volume medications. The US market for clorazepate is roughly $25.8 million annually — significant, but small compared to blockbuster benzodiazepines.

This doesn't mean you can't get it — but it does mean you may need to look beyond the nearest chain pharmacy. Independent pharmacies and smaller regional chains are often more willing and able to special-order less common medications.

Reason 3: Controlled Substance Rules Add Complexity

As a DEA Schedule IV controlled substance, clorazepate is subject to federal manufacturing quotas, strict inventory tracking requirements, and distributor limits on how much product can be shipped to any given pharmacy. These regulations — while critical for preventing diversion and misuse — create bottlenecks in the supply chain that make it harder for patients to access their medication, especially for lower-volume drugs.

Reason 4: Supply Chain Challenges Since COVID-19

The pharmaceutical supply chain has faced ongoing challenges since the COVID-19 pandemic. Raw material shortages, shipping delays, and disruptions in API (active pharmaceutical ingredient) manufacturing have affected many medications — including less commonly prescribed ones like Tranxene. These systemic pressures don't show up on an FDA shortage list, but they show up in pharmacy stock levels.

What You Can Do Right Now to Find Tranxene

Here are actionable steps to take when your pharmacy doesn't have Tranxene in stock:

Use medfinder to locate nearby pharmacies: medfinder calls pharmacies near you to find which ones can fill your Tranxene prescription, saving you hours of calling around on your own.

Try independent pharmacies: Smaller, independent pharmacies often have more flexible ordering relationships and may special-order Tranxene within 1-2 business days.

Ask about special orders: Even if your regular pharmacy doesn't stock clorazepate, they may be able to order it from their wholesaler within a day or two.

Refill early: Try to request refills at least a week before you run out. Running out of a benzodiazepine abruptly can cause dangerous withdrawal symptoms, including seizures — don't wait until the last day.

Keep your prescriber in the loop: If you are consistently unable to fill Tranxene, talk to your doctor. Alternatives like diazepam (Valium), clonazepam (Klonopin), or lorazepam (Ativan) may be appropriate, but never switch benzodiazepines on your own.

Is Tranxene Being Discontinued?

No. Tranxene is not being discontinued. The availability issues are driven by limited manufacturer interest, low prescribing volume, and controlled substance regulations — not by any decision to take the drug off the market. In fact, the addition of ANI Pharmaceuticals as a new generic manufacturer in 2026 is a positive sign that the market remains viable.

Don't Stop Tranxene Abruptly

This cannot be stressed enough: never stop taking Tranxene suddenly without medical supervision. Abrupt discontinuation of clorazepate after regular use can cause life-threatening withdrawal symptoms, including seizures, hallucinations, and severe rebound anxiety. If you're running low and can't find your prescription, call your doctor or pharmacist immediately.

The Bottom Line

Tranxene's availability challenges come from a combination of limited manufacturers, low prescribing volume, controlled substance regulations, and lingering supply chain pressures. But the drug is not gone — and with the right strategy, you can usually find it. Use medfinder to find pharmacies near you that currently have it in stock. For more tips, read our guides on how to find Tranxene in stock near you and the 2026 Tranxene shortage update.